Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinoids | 7 | 2021 | 28 | 3.030 |
Why?
|
Hypervitaminosis A | 4 | 2019 | 4 | 1.750 |
Why?
|
Autistic Disorder | 3 | 2019 | 37 | 1.660 |
Why?
|
Vitamin A | 8 | 2019 | 87 | 1.580 |
Why?
|
Liver Diseases | 2 | 2021 | 33 | 1.460 |
Why?
|
Rubella | 2 | 2019 | 15 | 1.380 |
Why?
|
Burkitt Lymphoma | 2 | 2017 | 23 | 1.210 |
Why?
|
Terrorism | 2 | 2023 | 12 | 1.190 |
Why?
|
Disasters | 3 | 2023 | 65 | 1.160 |
Why?
|
Malaria, Falciparum | 2 | 2017 | 90 | 0.950 |
Why?
|
Transsexualism | 1 | 2024 | 19 | 0.940 |
Why?
|
Herpesvirus 4, Human | 2 | 2017 | 33 | 0.760 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2017 | 15 | 0.750 |
Why?
|
Aggression | 2 | 2013 | 89 | 0.740 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2019 | 2 | 0.710 |
Why?
|
Mumps | 1 | 2019 | 2 | 0.710 |
Why?
|
Measles | 1 | 2019 | 7 | 0.700 |
Why?
|
Liver | 4 | 2019 | 479 | 0.700 |
Why?
|
Sex Education | 1 | 2019 | 30 | 0.690 |
Why?
|
Pregnancy in Adolescence | 1 | 2019 | 32 | 0.680 |
Why?
|
Persian Gulf Syndrome | 1 | 2019 | 2 | 0.670 |
Why?
|
School Health Services | 1 | 2019 | 81 | 0.650 |
Why?
|
Humans | 32 | 2024 | 37093 | 0.640 |
Why?
|
Stuttering | 1 | 2016 | 3 | 0.570 |
Why?
|
Plasmodium falciparum | 2 | 2017 | 135 | 0.530 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2015 | 3 | 0.510 |
Why?
|
Motor Vehicles | 1 | 2014 | 11 | 0.490 |
Why?
|
Health Services Needs and Demand | 4 | 2024 | 146 | 0.490 |
Why?
|
Automobile Driving | 1 | 2014 | 24 | 0.480 |
Why?
|
Leukocytes | 2 | 2011 | 72 | 0.480 |
Why?
|
Accidents, Traffic | 1 | 2014 | 42 | 0.480 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2013 | 1 | 0.460 |
Why?
|
Psychoses, Substance-Induced | 1 | 2013 | 2 | 0.460 |
Why?
|
Mefloquine | 1 | 2013 | 3 | 0.460 |
Why?
|
Depression, Postpartum | 1 | 2013 | 10 | 0.450 |
Why?
|
Health Surveys | 1 | 2015 | 373 | 0.450 |
Why?
|
Models, Biological | 2 | 2013 | 677 | 0.440 |
Why?
|
Dengue Virus | 1 | 2013 | 85 | 0.420 |
Why?
|
Erythrocytes | 1 | 2013 | 111 | 0.420 |
Why?
|
Breast Feeding | 1 | 2013 | 113 | 0.410 |
Why?
|
Violence | 2 | 2023 | 134 | 0.400 |
Why?
|
Wounds, Gunshot | 1 | 2011 | 28 | 0.370 |
Why?
|
Atherosclerosis | 1 | 2011 | 134 | 0.360 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2011 | 169 | 0.330 |
Why?
|
Brain Injuries | 1 | 2011 | 121 | 0.330 |
Why?
|
Brain | 1 | 2016 | 1346 | 0.330 |
Why?
|
Ascorbic Acid Deficiency | 1 | 2008 | 2 | 0.320 |
Why?
|
Exanthema | 1 | 2008 | 10 | 0.320 |
Why?
|
Bone Diseases | 1 | 2008 | 18 | 0.320 |
Why?
|
Growth Disorders | 1 | 2008 | 22 | 0.320 |
Why?
|
Respiratory Tract Infections | 1 | 2008 | 33 | 0.310 |
Why?
|
Heart Rate | 1 | 2008 | 253 | 0.300 |
Why?
|
Child | 5 | 2016 | 3131 | 0.300 |
Why?
|
Vaccination | 2 | 2019 | 288 | 0.290 |
Why?
|
Pregnancy | 4 | 2019 | 1549 | 0.270 |
Why?
|
Child, Preschool | 3 | 2016 | 1418 | 0.270 |
Why?
|
Pain | 1 | 2008 | 251 | 0.260 |
Why?
|
Mass Behavior | 1 | 2005 | 2 | 0.260 |
Why?
|
Malaria | 2 | 2017 | 78 | 0.250 |
Why?
|
Panic Disorder | 1 | 2005 | 100 | 0.230 |
Why?
|
Social Behavior | 1 | 2005 | 131 | 0.230 |
Why?
|
Female | 9 | 2019 | 20969 | 0.230 |
Why?
|
Risk Factors | 3 | 2019 | 3562 | 0.220 |
Why?
|
Protective Devices | 1 | 2002 | 4 | 0.220 |
Why?
|
Automobiles | 1 | 2002 | 6 | 0.220 |
Why?
|
Onchocerciasis | 1 | 2002 | 6 | 0.220 |
Why?
|
Total Quality Management | 1 | 2002 | 9 | 0.220 |
Why?
|
Security Measures | 1 | 2002 | 5 | 0.210 |
Why?
|
Social Control Policies | 1 | 2002 | 4 | 0.210 |
Why?
|
Infant, Newborn | 3 | 2013 | 894 | 0.210 |
Why?
|
Managed Care Programs | 1 | 2002 | 38 | 0.210 |
Why?
|
Cesarean Section | 1 | 2002 | 55 | 0.210 |
Why?
|
Adolescent | 4 | 2019 | 5363 | 0.210 |
Why?
|
Evidence-Based Medicine | 1 | 2002 | 97 | 0.210 |
Why?
|
Epidemiology | 1 | 2002 | 6 | 0.210 |
Why?
|
Pre-Eclampsia | 1 | 2003 | 61 | 0.210 |
Why?
|
Firearms | 1 | 2002 | 16 | 0.210 |
Why?
|
Hot Temperature | 1 | 2002 | 128 | 0.200 |
Why?
|
Fear | 1 | 2005 | 249 | 0.200 |
Why?
|
Infant | 3 | 2013 | 1046 | 0.200 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 204 | 0.200 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2003 | 221 | 0.200 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2003 | 103 | 0.200 |
Why?
|
Mississippi | 2 | 2019 | 122 | 0.190 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 53 | 0.190 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 52 | 0.190 |
Why?
|
Schools | 1 | 2002 | 260 | 0.180 |
Why?
|
Rubella virus | 1 | 2019 | 12 | 0.170 |
Why?
|
Pyridostigmine Bromide | 1 | 2019 | 5 | 0.170 |
Why?
|
Cholinesterase Inhibitors | 1 | 2019 | 43 | 0.160 |
Why?
|
Veterans | 1 | 2019 | 122 | 0.150 |
Why?
|
Male | 6 | 2016 | 20025 | 0.150 |
Why?
|
Blood Pressure | 2 | 2011 | 646 | 0.150 |
Why?
|
HIV-1 | 1 | 2003 | 706 | 0.150 |
Why?
|
Environmental Exposure | 1 | 2019 | 216 | 0.140 |
Why?
|
B-Lymphocytes | 1 | 2017 | 185 | 0.140 |
Why?
|
Health Promotion | 1 | 2002 | 653 | 0.140 |
Why?
|
Cohort Studies | 1 | 2019 | 1492 | 0.130 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2015 | 10 | 0.130 |
Why?
|
Cholestasis | 1 | 2015 | 9 | 0.130 |
Why?
|
India | 1 | 2015 | 88 | 0.130 |
Why?
|
Epidermis | 1 | 2015 | 24 | 0.130 |
Why?
|
Arabs | 2 | 2012 | 13 | 0.120 |
Why?
|
Keratinocytes | 1 | 2015 | 66 | 0.120 |
Why?
|
Safety | 1 | 2014 | 48 | 0.120 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 121 | 0.120 |
Why?
|
Public Health | 3 | 2010 | 372 | 0.120 |
Why?
|
Mastitis | 1 | 2013 | 2 | 0.120 |
Why?
|
Skin | 1 | 2015 | 174 | 0.110 |
Why?
|
Antifungal Agents | 1 | 2015 | 148 | 0.110 |
Why?
|
Milk | 1 | 2013 | 50 | 0.110 |
Why?
|
Hemolysis | 1 | 2013 | 40 | 0.110 |
Why?
|
Adult | 4 | 2013 | 11712 | 0.110 |
Why?
|
Mother-Child Relations | 1 | 2013 | 59 | 0.110 |
Why?
|
Hospitals, Public | 1 | 2012 | 12 | 0.110 |
Why?
|
Anemia | 1 | 2013 | 45 | 0.110 |
Why?
|
Oxidoreductases | 1 | 2013 | 87 | 0.110 |
Why?
|
Tretinoin | 1 | 2013 | 50 | 0.110 |
Why?
|
Hospital Costs | 1 | 2012 | 24 | 0.110 |
Why?
|
Rural Population | 1 | 2015 | 294 | 0.110 |
Why?
|
Endocytosis | 1 | 2013 | 113 | 0.100 |
Why?
|
Animals | 4 | 2013 | 15081 | 0.100 |
Why?
|
Premature Birth | 1 | 2013 | 75 | 0.100 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 661 | 0.100 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 352 | 0.100 |
Why?
|
Creatinine | 1 | 2011 | 103 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2011 | 139 | 0.100 |
Why?
|
Israel | 1 | 2011 | 19 | 0.100 |
Why?
|
Lymphocytes | 1 | 2011 | 118 | 0.100 |
Why?
|
Aged | 3 | 2011 | 6741 | 0.100 |
Why?
|
Medical Record Linkage | 1 | 2011 | 16 | 0.100 |
Why?
|
Neutrophils | 1 | 2011 | 131 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2010 | 29 | 0.090 |
Why?
|
Career Choice | 1 | 2010 | 45 | 0.090 |
Why?
|
Health Services Research | 1 | 2010 | 148 | 0.090 |
Why?
|
Primary Health Care | 1 | 2012 | 294 | 0.090 |
Why?
|
Monocytes | 1 | 2011 | 257 | 0.090 |
Why?
|
Mythology | 1 | 2008 | 2 | 0.080 |
Why?
|
HIV Infections | 1 | 2003 | 2303 | 0.080 |
Why?
|
Social Alienation | 1 | 2008 | 4 | 0.080 |
Why?
|
Follow-Up Studies | 1 | 2011 | 974 | 0.080 |
Why?
|
Relief Work | 1 | 2008 | 7 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2008 | 34 | 0.080 |
Why?
|
Incidence | 1 | 2011 | 922 | 0.080 |
Why?
|
Middle Aged | 3 | 2011 | 10129 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2008 | 63 | 0.080 |
Why?
|
Retrospective Studies | 2 | 2012 | 2026 | 0.080 |
Why?
|
Neural Pathways | 1 | 2008 | 124 | 0.080 |
Why?
|
Vitamins | 1 | 2008 | 94 | 0.080 |
Why?
|
Disaster Planning | 1 | 2008 | 52 | 0.080 |
Why?
|
United States | 4 | 2010 | 4223 | 0.070 |
Why?
|
Apoptosis | 1 | 2015 | 1398 | 0.070 |
Why?
|
Family | 1 | 2008 | 173 | 0.070 |
Why?
|
Minority Groups | 1 | 2010 | 596 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2008 | 322 | 0.060 |
Why?
|
Chronic Disease | 1 | 2008 | 484 | 0.060 |
Why?
|
Psychology | 1 | 2005 | 36 | 0.060 |
Why?
|
Terminally Ill | 1 | 2003 | 3 | 0.060 |
Why?
|
Patents as Topic | 1 | 2003 | 14 | 0.060 |
Why?
|
Sample Size | 1 | 2003 | 25 | 0.060 |
Why?
|
Accident Prevention | 1 | 2002 | 7 | 0.050 |
Why?
|
Ivermectin | 1 | 2002 | 2 | 0.050 |
Why?
|
Onchocerca volvulus | 1 | 2002 | 5 | 0.050 |
Why?
|
Unnecessary Procedures | 1 | 2002 | 9 | 0.050 |
Why?
|
Health Services Misuse | 1 | 2002 | 12 | 0.050 |
Why?
|
Vaginal Birth after Cesarean | 1 | 2002 | 7 | 0.050 |
Why?
|
Information Services | 1 | 2002 | 14 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2002 | 32 | 0.050 |
Why?
|
Mice | 1 | 2013 | 5913 | 0.050 |
Why?
|
Anthelmintics | 1 | 2002 | 18 | 0.050 |
Why?
|
Safety Management | 1 | 2002 | 18 | 0.050 |
Why?
|
Diet | 1 | 2008 | 801 | 0.050 |
Why?
|
Criminal Law | 1 | 2002 | 26 | 0.050 |
Why?
|
Juvenile Delinquency | 1 | 2002 | 44 | 0.050 |
Why?
|
Social Justice | 1 | 2002 | 55 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2002 | 161 | 0.050 |
Why?
|
Young Adult | 1 | 2011 | 4268 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2005 | 583 | 0.040 |
Why?
|
Diastole | 1 | 2010 | 42 | 0.020 |
Why?
|
Systole | 1 | 2010 | 61 | 0.020 |
Why?
|
Mentors | 1 | 2010 | 127 | 0.020 |
Why?
|
Regression Analysis | 1 | 2010 | 455 | 0.020 |
Why?
|
Peer Group | 1 | 2010 | 156 | 0.020 |
Why?
|
Survival | 1 | 2008 | 8 | 0.020 |
Why?
|
Foreign Medical Graduates | 1 | 2008 | 4 | 0.020 |
Why?
|
Anxiety, Separation | 1 | 2008 | 4 | 0.020 |
Why?
|
Louisiana | 1 | 2008 | 43 | 0.020 |
Why?
|
International Cooperation | 1 | 2008 | 46 | 0.020 |
Why?
|
Curriculum | 1 | 2010 | 265 | 0.020 |
Why?
|
Water Supply | 1 | 2008 | 57 | 0.020 |
Why?
|
Housing | 1 | 2008 | 59 | 0.020 |
Why?
|
Texas | 1 | 2008 | 324 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 2008 | 140 | 0.020 |
Why?
|
Food Supply | 1 | 2008 | 112 | 0.020 |
Why?
|
Prospective Studies | 1 | 2010 | 1378 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2010 | 494 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 2721 | 0.010 |
Why?
|